Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to lower risks of Alzheimer's disease in people with type 2 diabetes.
The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. The pharmacist ...
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own ...
Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback